# The Use of Tranexamic Acid to Reduce Perioperative Blood Loss During High Risk Spine Fusion Surgery

> **NCT01728636** · PHASE2 · COMPLETED · sponsor: **Northwestern University** · enrollment: 61 (actual)

## Conditions studied

- Curvature of Spine

## Interventions

- **DRUG:** Tranexamic Acid

## Key facts

- **NCT ID:** NCT01728636
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01-15
- **Primary completion:** 2017-12-30
- **Final completion:** 2017-12-30
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2021-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01728636

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01728636, "The Use of Tranexamic Acid to Reduce Perioperative Blood Loss During High Risk Spine Fusion Surgery". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01728636. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*